Skip to main content
. 2016 Sep 1;232(4):407–414. doi: 10.1159/000448135

Table 4.

Treatment satisfaction measured by visual analogue scale (VAS) from 0 to 10

VAS monotherapy etanercept VAS combination therapy etanercept and fumarates p value
Week 12 8.0 ± 1.47 8.1 ± 1.55 0.92
Week 24 8.1 ± 1.45 8.1 ± 1.43 0.95
Week 48 8.9 ± 1.17 8.2 ± 1.70 0.30

Results are expressed as means ± SD. p values assessed by the unpaired t test.